KR950011615A - 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조방법 - Google Patents

신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조방법 Download PDF

Info

Publication number
KR950011615A
KR950011615A KR1019940019984A KR19940019984A KR950011615A KR 950011615 A KR950011615 A KR 950011615A KR 1019940019984 A KR1019940019984 A KR 1019940019984A KR 19940019984 A KR19940019984 A KR 19940019984A KR 950011615 A KR950011615 A KR 950011615A
Authority
KR
South Korea
Prior art keywords
geri
coa
acat
cholesterol acyltransferase
activity inhibitor
Prior art date
Application number
KR1019940019984A
Other languages
English (en)
Other versions
KR0125129B1 (ko
Inventor
복성해
정태숙
김성욱
권병목
김영국
손광희
이항우
권용국
Original Assignee
김은영
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은영, 한국과학기술연구원 filed Critical 김은영
Priority to KR1019940019984A priority Critical patent/KR0125129B1/ko
Publication of KR950011615A publication Critical patent/KR950011615A/ko
Application granted granted Critical
Publication of KR0125129B1 publication Critical patent/KR0125129B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 토양으로부터 분리된 곰팡이 아스퍼질러스 푸미가투스(Aspergillus fumigatus) FM-F-37로부터 분리된, 아실-CoA : 콜레스테롤 아실전이효소의 저해제인 하기 구조식(I)의 GERI-BP001, 그의 유도체 및 그의 제조방법에 관한 것이다.

Description

신규 아실-코에이 : 콜레스테롤 아실전이효소(ACAT) 활성 저해물질 및 이의 제조 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 자외선-가시광선 분광기에 의한GERI-BP0001의 흡광도 분석 스펙트럼을 나타내는 도면이고,
제 2 도는 비율기록 적외선 분광기에 의한 GERI-BP001의 흡광도 분석 스펙트럼을 나타내는 도면이고,
제 3 도는 비율기록 적외선 분광기에 의한 GERI-BP001-C의 흡광도 분석 스펙트럼을 나타내는 도면이고,
제 4 도는 VG70-VSEQ 질량분석기에 의한 GERI-BP001의 HREI-MS 분자량 분석 스펙트럼을 나타내는 도면이고,
제 5 도는 VG70-VSEQ 질량분석기에 의한 GERI-BP001-A의 EI-MS 분자량 분석 스펙트럼을 나타내는 도면이고,
제 6 도는 VG70-VSEQ 질량분석기에 의한 GERI-BP001-B의 EI-MS 분자량 분석 스펙트럼을 나타내는 도면이고,
제 7 도는 브룩커(Bruker) AM-300에 의한 GERI-BP001의 300MHz에서의1H-NMR 분석 스펙트럼을 나타내는 도면이고,

Claims (6)

  1. 하기 구조식(I)의 신규 화합물 GERI-BP001 및 그의 유도체 :
  2. 제 1항에 있어서, 각각 하기 구조식(I-1), (I-2) 및 (I-3)을 갖는 유도체 GERI-BP001-A, GERI-BP001-B 및 GERI-BP001-C로 이루어진 그룹으로부터 선택된 유도체 :
  3. GERI-BP001 생산균주인 아스퍼질러스 푸미가투스(Aspergillus fumigatus) FM-F-37 균주(KCTC 0087BP).
  4. 아스퍼질러스 푸미가투스(Aspergillus fumigatus) FM-F-37 균주(KCTC 0087BP)를 배양함을 포함하는, GERI-BP001, GERI-BP001-A 또는 GERI-BP001-B의 제조방법
  5. GERI - BP001 화합물로 부터 핵진화성 치환반응에 의해 호학적으로 합성함을 포함하는 GERI - BP001-C의 제조방법.
  6. 활성물질로서 GERI -BP001, GERI -BP001-A GERI -BP001-B 또는 GERI -BP001-C 를 포함하는, 아실- CoA : 콜레스테롤 아실전이 효소(ACAT) 활성 저해제로 사용하기 위한 약학 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940019984A 1993-10-08 1994-08-13 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조 방법 KR0125129B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940019984A KR0125129B1 (ko) 1993-10-08 1994-08-13 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR930020886 1993-10-08
KR93-20886 1993-10-08
KR1019940019984A KR0125129B1 (ko) 1993-10-08 1994-08-13 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조 방법

Publications (2)

Publication Number Publication Date
KR950011615A true KR950011615A (ko) 1995-05-15
KR0125129B1 KR0125129B1 (ko) 1997-11-28

Family

ID=19365518

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940019984A KR0125129B1 (ko) 1993-10-08 1994-08-13 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조 방법

Country Status (2)

Country Link
US (1) US5597835A (ko)
KR (1) KR0125129B1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980081832A (ko) * 1997-04-30 1998-11-25

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9164104B2 (en) 2004-10-06 2015-10-20 The Brigham And Women's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
US8557550B2 (en) 2008-07-24 2013-10-15 Meija Seika Pharma Co., Ltd. Pyripyropene a biosynthetic gene
CA2787829A1 (en) 2010-01-26 2011-08-04 Meiji Seika Pharma Co., Ltd. Method for producing pyripyropene derivatives by the enzymatic method
BR112012019456B8 (pt) 2010-01-26 2022-08-02 Mmag Co Ltd Plasmídio compreendendo um ou mais polinucleotídeos e um promotor que é heterólogo para o um ou mais polinucleotídeos
EP2578084A4 (en) * 2010-05-24 2014-04-23 Meiji Seika Pharma Co Ltd MEANS OF COMBATING HARMFUL ORGANISMS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980081832A (ko) * 1997-04-30 1998-11-25

Also Published As

Publication number Publication date
US5597835A (en) 1997-01-28
KR0125129B1 (ko) 1997-11-28

Similar Documents

Publication Publication Date Title
NO20000205L (no) Ny kjemisk forbindelse egnet til anvendelse som et eksplosiv, mellomprodukt og fremgangsmõte for fremstilling av forbindelsen
JPS5490195A (en) Novel benzodiazepine compound
EA200001135A1 (ru) Способ получения изоксазолин-3-ил-ацилбензолов
HUP9902034A2 (hu) Szukcinimid- és maleimid citokin inhibitorvegyületek
HUP9903808A2 (hu) Eljárás szubsztituált aril-tejsavat tartalmazó 24 gyűrűatomos ciklodepszipeptidek előállítására
KR950011615A (ko) 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조방법
Marchand et al. Convenient synthesis of 2, 4-diacetylphloroglucinol, a natural antibiotic involved in the control of take-all disease of wheat
DK264388A (da) Fremgangsmaade til fremstilling af cyclooctaamylose
RU95112519A (ru) (3,4-ди-фторфенокси)метил оксиран и способ его получения
RU94033098A (ru) Способ производных 1-замещенного-5/4h/-тетразолинона
Gallardo et al. 10-Oximeguanacone, the first nitrogenated acetogenin derivative found to be a potent inhibitor of mitochondrial complex I
EP0790252A4 (en) FUMARIC ACID DERIVATIVE AND POLYMER THEREOF
EA199900528A1 (ru) Новые производные эритромицина, способ их получения и применения в качетве медикаментов
KR960001129A (ko) 신규 아실-코에이 : 콜레스테롤 아실전이효소(acat) 활성 저해물질 및 이의 제조방법
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
US3468905A (en) N-(1-halo-1-nitroalkylthio)dicarboximides
CA2164152A1 (en) New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
KR890003734A (ko) 신규한 nf-1616-904의 피라진옥사이드 화합물 및 이를 함유하는 약학 조성물
Sack Jr et al. Characterization of the products of alkylation of 2'-deoxyadenosine and 2'-deoxyguanosine by chloroethyl ethyl sulfide
KR960037043A (ko) 신규 항암제 조성물
JPS5545649A (en) Novel nootkatone and vetivone derivative, their novel intermediate, their preparation and use
US4820851A (en) Intermediates for antiatherosclerotic furochromones
US4614809A (en) Antiatherosclerotic furochromones and intermediates therefor
SU1467051A1 (ru) Способ получени замещенных N-ацил-1-амино-1,3-бутадиенов
CN109400588A (zh) 一种含氟三唑喹喔啉类杀菌剂、制备方法及其应用

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010921

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee